Christopher Biggs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christopher Biggs has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Lionel Tarassenko
NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
7 shared publications - Peter James Watkinson
Nuffield Department of Clinical Neurosciences University of Oxford Oxford UK
7 shared publications - Sarah Vollam
Nuffield Department of Clinical Neurosciences University of Oxford Oxford UK
6 shared publications - Carlos Areia
6th Briset street, Digital Science (United Kingdom), London, United Kingdom
4 shared publications - Andrew Farmer
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom
3 shared publications - Bethany K Lawson
NIHR Oxford Biomedical Research Centre, Oxford, England, United Kingdom
3 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e84233
Remote Vital Sign Monitoring in Acutely Unwell Hospital at Home Patients: Nonrandomized Feasibility Study
Background: Remote vital sign monitoring of acute hospital at home (aHAH) patients is recommended in policy without clear guidance on implementation. While such monitoring has the potential to improve patient care, there is limited evidence for its feasibility and acceptability. Objective: This study aimed to evaluate the feasibility and acceptability of using a remote, community-based monitoring system using a vital sign wearable patch and pulse oximeter in aHAH patients. Methods: In this nonrandomized feasibility study, we recruited patients from an aHAH service in Oxford, United Kingdom, between January and October 2024. Eligible patients were aged 18 years and older with an acute illness (lower respiratory tract infection, cellulitis, urinary tract infection, systemic evidence of acute infection, acute kidney injury, or heart failure with acute fluid overload) requiring aHAH care. Pregnant women and those with contraindications to monitoring were excluded. Participants were asked to wear a chest patch to estimate their heart rate and respiratory rate (passive monitoring), and to intermittently check their oxygen saturations, blood pressure, and temperature (active monitoring). Participants were asked to complete a Technology Acceptance Questionnaire. All aHAH patients were screened. Recruitment was nonconsecutive due to the availability of the research team. Participants were monitored for 7 days or until discharge from the aHAH service, whichever was shorter. Fixed time windows were used to assess real-time vital sign data coverage during each participant’s monitoring period. The primary outcomes were the proportion of 4-hour monitoring windows with a recorded heart rate and 12-hour daytime windows with a recorded oxygen saturation level. Time-series analyses and descriptive statistics were used for quantitative data. Content analysis was used to analyze the open-ended comments in the questionnaire. Results: In total, 29 participants were recruited and 3 immediately withdrew from the study. Participants were monitored for 4.8 (IQR 2.9-6.2) days on average. Overall, 89% (600/674) of the 4-hour monitoring windows had a heart rate and 75.4% (508/674) had a respiratory rate recorded in real-time. For the 12-hour daytime windows, 58.1% (75/129) had an oxygen saturation, 54.3% (70/129) had a blood pressure, and 51.2% (66/129) had a temperature recorded. Data coverage was higher for passive monitoring compared to active monitoring. Most participants who had capacity found the combined monitoring system easy to use and thought it was useful for their health care. Conclusions: Remote monitoring of vital signs in aHAH patients is feasible. Good data coverage was achieved for the passive monitoring, which did not require specific actions by the participants or their caregivers. Further work is required to ascertain which patients would benefit most from this monitoring.
- 25 September 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e84233
Open AccessRemote Vital Sign Monitoring in Acutely Unwell Hospital at Home Patients: Nonrandomized Feasibility Study
Background: Remote vital sign monitoring of acute hospital at home (aHAH) patients is recommended in policy without clear guidance on implementation. While such monitoring has the potential to improve patient care, there is limited evidence for its feasibility and acceptability. Objective: This study aimed to evaluate the feasibility and acceptability of using a remote, community-based monitoring system using a vital sign wearable patch and pulse oximeter in aHAH patients. Methods: In this nonrandomized feasibility study, we recruited patients from an aHAH service in Oxford, United Kingdom, between January and October 2024. Eligible patients were aged 18 years and older with an acute illness (lower respiratory tract infection, cellulitis, urinary tract infection, systemic evidence of acute infection, acute kidney injury, or heart failure with acute fluid overload) requiring aHAH care. Pregnant women and those with contraindications to monitoring were excluded. Participants were asked to wear a chest patch to estimate their heart rate and respiratory rate (passive monitoring), and to intermittently check their oxygen saturations, blood pressure, and temperature (active monitoring). Participants were asked to complete a Technology Acceptance Questionnaire. All aHAH patients were screened. Recruitment was nonconsecutive due to the availability of the research team. Participants were monitored for 7 days or until discharge from the aHAH service, whichever was shorter. Fixed time windows were used to assess real-time vital sign data coverage during each participant’s monitoring period. The primary outcomes were the proportion of 4-hour monitoring windows with a recorded heart rate and 12-hour daytime windows with a recorded oxygen saturation level. Time-series analyses and descriptive statistics were used for quantitative data. Content analysis was used to analyze the open-ended comments in the questionnaire. Results: In total, 29 participants were recruited and 3 immediately withdrew from the study. Participants were monitored for 4.8 (IQR 2.9-6.2) days on average. Overall, 89% (600/674) of the 4-hour monitoring windows had a heart rate and 75.4% (508/674) had a respiratory rate recorded in real-time. For the 12-hour daytime windows, 58.1% (75/129) had an oxygen saturation, 54.3% (70/129) had a blood pressure, and 51.2% (66/129) had a temperature recorded. Data coverage was higher for passive monitoring compared to active monitoring. Most participants who had capacity found the combined monitoring system easy to use and thought it was useful for their health care. Conclusions: Remote monitoring of vital signs in aHAH patients is feasible. Good data coverage was achieved for the passive monitoring, which did not require specific actions by the participants or their caregivers. Further work is required to ascertain which patients would benefit most from this monitoring.
- Open Access
Screening for hypertension in the inpatient environment (SHINE): a prospective diagnostic accuracy study among adult hospital patients
Background: Hypertension is the leading risk factor for death globally. Undiagnosed hypertension is common, but the incidence in hospitalised patients is unclear. There are calls for universal facility-based screening for hypertension among all attending patients. The hospital inpatient setting, where blood pressure (BP) is measured routinely and repeatedly, presents an ideal opportunity. However, international hypertension guidelines do not include inpatient BP thresholds for diagnostic or treatment purposes. We investigated the performance of current UK community BP thresholds for diagnosing hypertension in the hospital setting. Objectives: Investigate the diagnostic performance of the current UK ambulatory BP diagnostic thresholds for systolic and diastolic hypertension in the hospital setting against the reference test of community-based ambulatory BP monitoring (ABPM). Design: A prospective diagnostic accuracy study. Setting: Hospital inpatients admitted to three UK centres were approached. Follow-up ABPM was delivered in the community. Participants: Eligible patients were aged between 18 and 80 years, with no prior diagnosis of, or prescription for hypertension, and whose mean cumulative daytime BP was 120 mm Hg to 179 mm Hg systolic and ≤109 mm Hg diastolic from the 24th hour of their hospital admission. Interventions: Participants received 24-hour ABPM 4–26 weeks post-discharge, as the reference test for hypertension, with UK diagnostic thresholds of an average daytime BP of ≥135 mm Hg systolic and ≥85 mm Hg diastolic applied. Participants found to be severely hypertensive at the ABPM fitting appointment were also considered reference-test positive but did not proceed with ABPM. Primary and secondary outcome measures: The diagnostic performance of a mean daytime in-hospital BP of ≥135 mm Hg systolic or ≥85 mm Hg diastolic (index test) for the prediction of hypertension diagnosed on ABPM (reference test) was assessed using sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) as primary outcome measures. Additionally, we explored the accuracy of a range of alternative in-hospital systolic and diastolic BP thresholds against the same reference test. Results: 351 participants were enrolled and 206 completed the study protocol. The average age of the 206 participants was 53 years, 55% were male, and 91 (44%) had daytime community hypertension on ABPM reference testing. Of 107 participants with raised in-hospital daytime BP, 59 (55%) had daytime community hypertension. When assessing the performance of the index test for detecting daytime community hypertension, sensitivity was 65% (59/91, 54% to 75%) and specificity was 58% (67/115, 49% to 67%). The PPV was 55% (59/107, 45% to 65%) and NPV was 68% (67/99, 58% to 77%), respectively. A further 45/206 participants (23%) had night-time community hypertension when assessed using European diagnostic thresholds for nocturnal hypertension (120 mm Hg systolic or 70 mm Hg diastolic), while 25/107 of those with raised in-hospital daytime BP (23%) had night-time community hypertension. When assessing the performance of the index test for detecting either day or night-time community hypertension, sensitivity was 62% (84/135, 53% to 70%) and specificity was 68% (48/71, 55% to 78%). The PPV was 79% (84/107, 70% to 86%) and NPV was 48% (48/99, 38% to 59%). Conclusions: Undiagnosed hypertension is common in hospitalised patients, particularly those with raised in-hospital BP. While in-hospital BP alone is an imperfect predictor and should not be used as a stand-alone diagnostic test, this could serve as a trigger for further assessment of BP in the community after discharge. Trial registration number: The study protocol was registered with the ISCTRN Registry ( ISRCTN80586284 ).
Open AccessScreening for hypertension in the inpatient environment (SHINE): a prospective diagnostic accuracy study among adult hospital patients
Background: Hypertension is the leading risk factor for death globally. Undiagnosed hypertension is common, but the incidence in hospitalised patients is unclear. There are calls for universal facility-based screening for hypertension among all attending patients. The hospital inpatient setting, where blood pressure (BP) is measured routinely and repeatedly, presents an ideal opportunity. However, international hypertension guidelines do not include inpatient BP thresholds for diagnostic or treatment purposes. We investigated the performance of current UK community BP thresholds for diagnosing hypertension in the hospital setting. Objectives: Investigate the diagnostic performance of the current UK ambulatory BP diagnostic thresholds for systolic and diastolic hypertension in the hospital setting against the reference test of community-based ambulatory BP monitoring (ABPM). Design: A prospective diagnostic accuracy study. Setting: Hospital inpatients admitted to three UK centres were approached. Follow-up ABPM was delivered in the community. Participants: Eligible patients were aged between 18 and 80 years, with no prior diagnosis of, or prescription for hypertension, and whose mean cumulative daytime BP was 120 mm Hg to 179 mm Hg systolic and ≤109 mm Hg diastolic from the 24th hour of their hospital admission. Interventions: Participants received 24-hour ABPM 4–26 weeks post-discharge, as the reference test for hypertension, with UK diagnostic thresholds of an average daytime BP of ≥135 mm Hg systolic and ≥85 mm Hg diastolic applied. Participants found to be severely hypertensive at the ABPM fitting appointment were also considered reference-test positive but did not proceed with ABPM. Primary and secondary outcome measures: The diagnostic performance of a mean daytime in-hospital BP of ≥135 mm Hg systolic or ≥85 mm Hg diastolic (index test) for the prediction of hypertension diagnosed on ABPM (reference test) was assessed using sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) as primary outcome measures. Additionally, we explored the accuracy of a range of alternative in-hospital systolic and diastolic BP thresholds against the same reference test. Results: 351 participants were enrolled and 206 completed the study protocol. The average age of the 206 participants was 53 years, 55% were male, and 91 (44%) had daytime community hypertension on ABPM reference testing. Of 107 participants with raised in-hospital daytime BP, 59 (55%) had daytime community hypertension. When assessing the performance of the index test for detecting daytime community hypertension, sensitivity was 65% (59/91, 54% to 75%) and specificity was 58% (67/115, 49% to 67%). The PPV was 55% (59/107, 45% to 65%) and NPV was 68% (67/99, 58% to 77%), respectively. A further 45/206 participants (23%) had night-time community hypertension when assessed using European diagnostic thresholds for nocturnal hypertension (120 mm Hg systolic or 70 mm Hg diastolic), while 25/107 of those with raised in-hospital daytime BP (23%) had night-time community hypertension. When assessing the performance of the index test for detecting either day or night-time community hypertension, sensitivity was 62% (84/135, 53% to 70%) and specificity was 68% (48/71, 55% to 78%). The PPV was 79% (84/107, 70% to 86%) and NPV was 48% (48/99, 38% to 59%). Conclusions: Undiagnosed hypertension is common in hospitalised patients, particularly those with raised in-hospital BP. While in-hospital BP alone is an imperfect predictor and should not be used as a stand-alone diagnostic test, this could serve as a trigger for further assessment of BP in the community after discharge. Trial registration number: The study protocol was registered with the ISCTRN Registry ( ISRCTN80586284 ).
- Open Access
- 16 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Remote Vital Sign Monitoring in Acutely Unwell Hospital at Home Patients: Nonrandomized Feasibility Study (Preprint)
BACKGROUND Remote vital sign monitoring of acute hospital at home (aHAH) patients is recommended in policy without clear guidance on implementation. While such monitoring has the potential to improve patient care, there is limited evidence for its feasibility and acceptability. OBJECTIVE This study aimed to evaluate the feasibility and acceptability of using a remote, community-based monitoring system using a vital sign wearable patch and pulse oximeter in aHAH patients. METHODS In this nonrandomized feasibility study, we recruited patients from an aHAH service in Oxford, United Kingdom, between January and October 2024. Eligible patients were aged 18 years and older with an acute illness (lower respiratory tract infection, cellulitis, urinary tract infection, systemic evidence of acute infection, acute kidney injury, or heart failure with acute fluid overload) requiring aHAH care. Pregnant women and those with contraindications to monitoring were excluded. Participants were asked to wear a chest patch to estimate their heart rate and respiratory rate (passive monitoring), and to intermittently check their oxygen saturations, blood pressure, and temperature (active monitoring). Participants were asked to complete a Technology Acceptance Questionnaire. All aHAH patients were screened. Recruitment was nonconsecutive due to the availability of the research team. Participants were monitored for 7 days or until discharge from the aHAH service, whichever was shorter. Fixed time windows were used to assess real-time vital sign data coverage during each participant’s monitoring period. The primary outcomes were the proportion of 4-hour monitoring windows with a recorded heart rate and 12-hour daytime windows with a recorded oxygen saturation level. Time-series analyses and descriptive statistics were used for quantitative data. Content analysis was used to analyze the open-ended comments in the questionnaire. RESULTS In total, 29 participants were recruited and 3 immediately withdrew from the study. Participants were monitored for 4.8 (IQR 2.9-6.2) days on average. Overall, 89% (600/674) of the 4-hour monitoring windows had a heart rate and 75.4% (508/674) had a respiratory rate recorded in real-time. For the 12-hour daytime windows, 58.1% (75/129) had an oxygen saturation, 54.3% (70/129) had a blood pressure, and 51.2% (66/129) had a temperature recorded. Data coverage was higher for passive monitoring compared to active monitoring. Most participants who had capacity found the combined monitoring system easy to use and thought it was useful for their health care. CONCLUSIONS Remote monitoring of vital signs in aHAH patients is feasible. Good data coverage was achieved for the passive monitoring, which did not require specific actions by the participants or their caregivers. Further work is required to ascertain which patients would benefit most from this monitoring.
- 16 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessRemote Vital Sign Monitoring in Acutely Unwell Hospital at Home Patients: Nonrandomized Feasibility Study (Preprint)
BACKGROUND Remote vital sign monitoring of acute hospital at home (aHAH) patients is recommended in policy without clear guidance on implementation. While such monitoring has the potential to improve patient care, there is limited evidence for its feasibility and acceptability. OBJECTIVE This study aimed to evaluate the feasibility and acceptability of using a remote, community-based monitoring system using a vital sign wearable patch and pulse oximeter in aHAH patients. METHODS In this nonrandomized feasibility study, we recruited patients from an aHAH service in Oxford, United Kingdom, between January and October 2024. Eligible patients were aged 18 years and older with an acute illness (lower respiratory tract infection, cellulitis, urinary tract infection, systemic evidence of acute infection, acute kidney injury, or heart failure with acute fluid overload) requiring aHAH care. Pregnant women and those with contraindications to monitoring were excluded. Participants were asked to wear a chest patch to estimate their heart rate and respiratory rate (passive monitoring), and to intermittently check their oxygen saturations, blood pressure, and temperature (active monitoring). Participants were asked to complete a Technology Acceptance Questionnaire. All aHAH patients were screened. Recruitment was nonconsecutive due to the availability of the research team. Participants were monitored for 7 days or until discharge from the aHAH service, whichever was shorter. Fixed time windows were used to assess real-time vital sign data coverage during each participant’s monitoring period. The primary outcomes were the proportion of 4-hour monitoring windows with a recorded heart rate and 12-hour daytime windows with a recorded oxygen saturation level. Time-series analyses and descriptive statistics were used for quantitative data. Content analysis was used to analyze the open-ended comments in the questionnaire. RESULTS In total, 29 participants were recruited and 3 immediately withdrew from the study. Participants were monitored for 4.8 (IQR 2.9-6.2) days on average. Overall, 89% (600/674) of the 4-hour monitoring windows had a heart rate and 75.4% (508/674) had a respiratory rate recorded in real-time. For the 12-hour daytime windows, 58.1% (75/129) had an oxygen saturation, 54.3% (70/129) had a blood pressure, and 51.2% (66/129) had a temperature recorded. Data coverage was higher for passive monitoring compared to active monitoring. Most participants who had capacity found the combined monitoring system easy to use and thought it was useful for their health care. CONCLUSIONS Remote monitoring of vital signs in aHAH patients is feasible. Good data coverage was achieved for the passive monitoring, which did not require specific actions by the participants or their caregivers. Further work is required to ascertain which patients would benefit most from this monitoring.
- 16 February 2022
- Published by Elsevier in Physiotherapy
- Vol. 114, e60-e61
Vital sign monitoring methods and perceived reliability differences between physiotherapists and nurses. A cross-sectional survey study
- 16 February 2022
- Published by Elsevier in Physiotherapy
- Vol. 114, e60-e61
Vital sign monitoring methods and perceived reliability differences between physiotherapists and nurses. A cross-sectional survey study
- Open Access
- 15 November 2021
- Published by Springer Nature in Critical Care
- Vol. 25 (1) , 1-2
Continuous wireless postoperative monitoring using wearable devices: further device innovation is needed
- 15 November 2021
- Published by Springer Nature in Critical Care
- Vol. 25 (1) , 1-2
Open AccessContinuous wireless postoperative monitoring using wearable devices: further device innovation is needed
- Open Access
- 28 September 2021
- Published by Springer Nature in Critical Care
- Vol. 25 (1) , 1-17
The impact of wearable continuous vital sign monitoring on deterioration detection and clinical outcomes in hospitalised patients: a systematic review and meta-analysis
Background: Timely recognition of the deteriorating inpatient remains challenging. Wearable monitoring systems (WMS) may augment current monitoring practices. However, there are many barriers to implementation in the hospital environment, and evidence describing the clinical impact of WMS on deterioration detection and patient outcome remains unclear.Objective: To assess the impact of vital-sign monitoring on detection of deterioration and related clinical outcomes in hospitalised patients using WMS, in comparison with standard care.Methods: A systematic search was conducted in August 2020 using MEDLINE, Embase, CINAHL, Cochrane Database of Systematic Reviews, CENTRAL, Health Technology Assessment databases and grey literature. Studies comparing the use of WMS against standard care for deterioration detection and related clinical outcomes in hospitalised patients were included. Deterioration related outcomes (primary) included unplanned intensive care admissions, rapid response team or cardiac arrest activation, total and major complications rate. Other clinical outcomes (secondary) included in-hospital mortality and hospital length of stay. Exploratory outcomes included alerting system parameters and clinical trial registry information.Results: Of 8706 citations, 10 studies with different designs met the inclusion criteria, of which 7 were included in the meta-analyses. Overall study quality was moderate. The meta-analysis indicated that the WMS, when compared with standard care, was not associated with significant reductions in intensive care transfers (risk ratio, RR 0.87; 95% confidence interval, CI 0.66–1.15), rapid response or cardiac arrest team activation (RR 0.84; 95% CI 0.69–1.01), total (RR 0.77; 95% CI 0.44–1.32) and major (RR 0.55; 95% CI 0.24–1.30) complications prevalence. There was also no statistically significant association with reduced mortality (RR 0.48; 95% CI 0.18–1.29) and hospital length of stay (mean difference, MD − 0.09; 95% CI − 0.43 to 0.44).Conclusion: This systematic review indicates that there is no current evidence that implementation of WMS impacts early deterioration detection and associated clinical outcomes, as differing design/quality of available studies and diversity of outcome measures make it difficult to reach a definite conclusion. Our narrative findings suggested that alarms should be adjusted to minimise false alarms and promote rapid clinical action in response to deterioration.PROSPERO Registration number:CRD42020188633.
- 28 September 2021
- Published by Springer Nature in Critical Care
- Vol. 25 (1) , 1-17
Open AccessThe impact of wearable continuous vital sign monitoring on deterioration detection and clinical outcomes in hospitalised patients: a systematic review and meta-analysis
Background: Timely recognition of the deteriorating inpatient remains challenging. Wearable monitoring systems (WMS) may augment current monitoring practices. However, there are many barriers to implementation in the hospital environment, and evidence describing the clinical impact of WMS on deterioration detection and patient outcome remains unclear.Objective: To assess the impact of vital-sign monitoring on detection of deterioration and related clinical outcomes in hospitalised patients using WMS, in comparison with standard care.Methods: A systematic search was conducted in August 2020 using MEDLINE, Embase, CINAHL, Cochrane Database of Systematic Reviews, CENTRAL, Health Technology Assessment databases and grey literature. Studies comparing the use of WMS against standard care for deterioration detection and related clinical outcomes in hospitalised patients were included. Deterioration related outcomes (primary) included unplanned intensive care admissions, rapid response team or cardiac arrest activation, total and major complications rate. Other clinical outcomes (secondary) included in-hospital mortality and hospital length of stay. Exploratory outcomes included alerting system parameters and clinical trial registry information.Results: Of 8706 citations, 10 studies with different designs met the inclusion criteria, of which 7 were included in the meta-analyses. Overall study quality was moderate. The meta-analysis indicated that the WMS, when compared with standard care, was not associated with significant reductions in intensive care transfers (risk ratio, RR 0.87; 95% confidence interval, CI 0.66–1.15), rapid response or cardiac arrest team activation (RR 0.84; 95% CI 0.69–1.01), total (RR 0.77; 95% CI 0.44–1.32) and major (RR 0.55; 95% CI 0.24–1.30) complications prevalence. There was also no statistically significant association with reduced mortality (RR 0.48; 95% CI 0.18–1.29) and hospital length of stay (mean difference, MD − 0.09; 95% CI − 0.43 to 0.44).Conclusion: This systematic review indicates that there is no current evidence that implementation of WMS impacts early deterioration detection and associated clinical outcomes, as differing design/quality of available studies and diversity of outcome measures make it difficult to reach a definite conclusion. Our narrative findings suggested that alarms should be adjusted to minimise false alarms and promote rapid clinical action in response to deterioration.PROSPERO Registration number:CRD42020188633.
- Open Access
Protocol for a systematic review assessing ambulatory vital sign monitoring impact on deterioration detection and related clinical outcomes in hospitalised patients
Introduction Ambulatory monitoring systems (AMS) can facilitate early detection of clinical deterioration, and have the potential to improve hospitalised patient outcomes. The objective of this systematic review is to assess the impact of vital signs monitoring on detection of deterioration and related outcomes in hospitalised patients using AMS, in comparison with standard care. Methods and analysis A systematic search was conducted on 27 August 2020 in MEDLINE, Embase, CINAHL, Cochrane Database of Systematic Reviews, CENTRAL and Health Technology Assessment databases, as well as grey literature. Search results will be reviewed in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis checklist for systematic reviews. Studies comparing the use of ambulatory monitoring devices against standard care for deterioration detection and related clinical outcomes in hospitalised patients will be included and further clinical and other outcomes will also be explored. Deterioration-related outcomes may include (but not limited to) unplanned intensive care admissions, rapid response team activation and unscheduled emergency interventions, as defined by the included studies. Two reviewers will independently extract study data and assess the quality and risk of bias of included studies. Where possible, a meta-analysis will be conducted and quantitative results presented. Alternatively, a narrative synthesis will be reported. Ethics and dissemination Ethical approval is not required for this study as no primary data will be collected. This study is part of our virtual High Dependency Unit project and will be disseminated through peer-reviewed publications, public and scientific conference presentations. PROSPERO registration number CRD42020188633.
Open AccessProtocol for a systematic review assessing ambulatory vital sign monitoring impact on deterioration detection and related clinical outcomes in hospitalised patients
Introduction Ambulatory monitoring systems (AMS) can facilitate early detection of clinical deterioration, and have the potential to improve hospitalised patient outcomes. The objective of this systematic review is to assess the impact of vital signs monitoring on detection of deterioration and related outcomes in hospitalised patients using AMS, in comparison with standard care. Methods and analysis A systematic search was conducted on 27 August 2020 in MEDLINE, Embase, CINAHL, Cochrane Database of Systematic Reviews, CENTRAL and Health Technology Assessment databases, as well as grey literature. Search results will be reviewed in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis checklist for systematic reviews. Studies comparing the use of ambulatory monitoring devices against standard care for deterioration detection and related clinical outcomes in hospitalised patients will be included and further clinical and other outcomes will also be explored. Deterioration-related outcomes may include (but not limited to) unplanned intensive care admissions, rapid response team activation and unscheduled emergency interventions, as defined by the included studies. Two reviewers will independently extract study data and assess the quality and risk of bias of included studies. Where possible, a meta-analysis will be conducted and quantitative results presented. Alternatively, a narrative synthesis will be reported. Ethics and dissemination Ethical approval is not required for this study as no primary data will be collected. This study is part of our virtual High Dependency Unit project and will be disseminated through peer-reviewed publications, public and scientific conference presentations. PROSPERO registration number CRD42020188633.